Blue Horseshoe Stocks: Options Success & More

Options Success

Netflix, Inc. NFLX – Options  -We signaled a range of options contracts on NFLX in yesterday’s premarket report, citing the earnings beat of the previous afternoon. We specifically mentioned that we were looking out for a dip-and-rip formation on the chart and the stock produced a classic example of such. NFLX’s big day, which ultimately facilitated those multi-bag profit opportunities, was fueled by an impressive 5 million new subscribers to the Netflix streaming service.

Right out of the gate, it dipped briefly to the high $175 area before going on an hours-long bullish push to the upper $184’s. That activity led to some really nice gains in our highlighted options, the NFLX Weekly $172.50-180 Calls:

$172.50 Calls – Range: 3.80-12.75 – Max Gain: 236%
$175 Calls – Range: 2.50-10.50 – Max Gain: 320%
$177.50 Calls – Range: 1.40-8.30– Max Gain: 493%
$180 Calls – Range: .85-6.42 – Max Gain: 655%

_______

Nutanix, Inc. NTNX – We also want to circle back to recap the moves made by an options idea we included in Friday morning’s report. NTNX continued to climb yesterday, and so the NTNX 7/21 $20-25 Calls we signaled have turned up some really nice moves.

$20 Calls – Range: 1.65-3.90 – Max Gain: 136%
$22.50 Calls – Range: .40-1.56 – Max Gain: 290%
$25 Calls – Range: .05-.28 – Max Gain: 460%


Yesterday’s Movers

We also had a number of the stocks that we highlighted in yesterday’s report yield chances for solid gains, and of them gave us a reason to look out for further moves:

Caprico Therapeutics, Inc. CAPR – The biggest gainer of the day from our mentions and on the NASDAQ itself, CAPR traded in a range from a low of .901, on up to a high of 1.62. That worked out to an 80% rip, and it came on an incredible 291X the monthly average volume.

The huge session was catalyzed by the announcement that the FDA has granted Rare Pediatric Disease Designation to CAP-1002, Capricor’s development candidate for the treatment of Duchenne muscular dystrophy. (>>View PR)
_________

Marijuana Company of America, Inc. MCOA – There was a nice move in MCOA as the stock traded up 38% from .02685-.037 on close to five times its monthly average volume, and the table may be set for a continuation of the trend with a new PR hitting the wires this morning.

The company is reporting that it has received the first round of funding for a joint venture to construct a 30,000 sq. ft. greenhouse grow facility in Oroville, Washington. Once completed, the greenhouse facility will accommodate a cannabis production and processing tenant with a Tier 3, I-502 license… (>>View PR)
_________

Novavax Inc. NVAX – This one recorded a very respectable gain on the day, running steadily from 1.17 up to 1.53, a 31% upswing. More importantly, the stock maintained the vast majority of its daily advance into the close, so we’ll want to continue to track NVAX as well.


Extended Watchlist:
AEZS, ALSK, NCMI, XGTI, LEXG

Blue Horseshoe Stocks: BMXI Recap & More

Brookmount Explorations Inc. BMXI

Having written our daily newsletters for such a long time, occasionally we run back across a stock that we haven’t seen in quite some time, and that was the case with BMXI. Before yesterday’s signal on it, we hadn’t mentioned it since May of 2012 back when it was regularly trading in the subpenny range.

It found its way to our radar screens and into our premarket report yesterday morning on word of a promotion (Disclosure: We were not involved in the deal), and what followed was one of the biggest breakouts the stock has ever had. From a low of .0831 it soared to a new all-time high of .1279 . That’s an intraday gain of 54% which came on enormous volume.


Delta Air Lines, Inc. DAL – Options Idea

Our regular followers know that we’re always on the lookout to take advantage of the hype-fueled moves that stocks tend to make following an earnings report, using their options chains. Delta whiffed on profits this quarter, falling well short of expectations on the Street, and despite issuing solid guidance for Q3, we want to signal a range of short-term puts to watch into the end of the week.

DAL stock was already at a top, and in a price range where profit-takers could be a factor as well. For that reason, we are going to radar the DAL Weekly $55.50-53.50 Puts.


OncBioMune Pharmaceuticals, Inc. OBMP

OBMP had an update that it issued this morning on its mid-stage cancer treatment (>>View PR), but our interest is really being drawn to this play for technical reasons.

As you can see below, the stock recently established a new annual low, followed by a rebound off of that low, and now it is making its way back down to find support. We will be interested in this as a potential rebound play in the event that the stock maintains support at or above a nickel. We’re presently looking at an impending bearish cross on the MACD so we’ll see if the stock can hang in there without losing more than a penny off of its current PPS.


Extended Watchlist:
SPEX, XGTI, CODX, OCLR, CIE, AAOI

Blue Horseshoe Stocks: SNDX Recap, Options & More

Syndax Pharmaceuticals, Inc. SNDX

Despite the markets getting crushed yesterday we managed to find and tag in our premarket report, what would ultimately be the NASDAQ’s top gainer of the day. SNDX had been gradually coming up off a bottom in the few sessions prior, but yesterday things really kicked into gear.

It traded in a range from 10.76 to 15.335, a fantastic intraday move of 43% which is really impressive for a $10+ stock. That move inside of the first 90 minutes of the session. That was followed by a dip-and-rip pattern from 12.16 and back to 13.62; a 12% rebound into a strong close at 13.58

The stock traded 56x its 30-day average volume yesterday, and held more than half of its daily advance, so we’ll be treating this as a potential momentum play as we head into week’s end, looking out for higher highs and higher lows out of SNDX.


Fresh Options Ideas

Speaking of the markets getting crushed, it appears as if we may see a continuation of that pattern today, so we want to have a few sets of options ideas to fall back on in the event of a continued slide.

Alibaba Group Holding Ltd. BABA – BABA had been on an incredible bullish run for the better of part of 2017 thus far as you can plainly see on the chart snapshot we’ve included here. You can also see that the strength index is sharply declining after having recently been indicating the stock was extremely overbought.  We can also see the MACD pinching toward a bearish cross.

That’s why, along with an earnings miss in the premarket and the overall current of the markets as a whole, we’re looking at the BABA Weekly $120-117 Puts for potential quick-strike swing trades.


____

SPDR S&P 500 ETF Trust (SPY)  – Also in the vein of our general bearish view of today’s overall conditions, we want to line up a set of SPY Puts for observation. Our regular readers know that the SPY is one of our favorite market analogs, and has been a wellspring of gains for us on the options front when we correctly gauge investor sentiment.

Today we want to put the SPY Weekly $237-235 Puts on watch, as a sustained tumultuous period for stocks would likely produce some good chances for us there.


Extended Watchlist:
P, GLYC, CYTR, ETRM, XGTI, VSLR